Updated Date:
23 Sep 2025
Product Detail:
PAVTIDE MDI 125/25 fluticasone propionate 125 mcg/salmeterol (as xinafoate) 25 mcg inhalation pressurised aerosol can metered dose (with counter)
Shortage Status:
Resolved
AUST R:
208670
Availability:
Available
Active Ingredient:
fluticasone propionate~salmeterol xinafoate
Reason:
Unexpected increase in consumer demand
Dosage Form:
Inhalation,pressurised
Supply Impact Dates
From 15 Sep 2025
To 23 Sep 2025
Management Action:
